Access cutting-edge inflammatory myopathies treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access inflammatory myopathies specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related inflammatory myopathies treatment provided free
The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease activity in participants with moderate to severe Idiopathic Inflammatory Myopathies (IIM) \[polymyositis (PM) or dermatomyositis (DM)\] while receiving standard of care (SoC) treatment.
Sponsor: AstraZeneca
Check if you qualify for this inflammatory myopathies clinical trial in Washington Dc, DC
If you're searching for inflammatory myopathies treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory myopathies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.